Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery
Launched by UNIVERSITY HOSPITAL, GHENT · Jul 28, 2021
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how genital gender affirming surgery affects genital sensitivity and sexual function in individuals with gender dysphoria. Gender dysphoria is the distress someone may feel when their gender identity does not match their assigned sex at birth. The goal of the trial is to understand what patients can expect in terms of sensitivity and sexual functioning after they undergo this type of surgery.
To be eligible for the trial, participants must be at least 18 years old, identify as transgender or gender non-conforming, and wish to have genital gender affirming surgery. They should also be in good health and able to attend follow-up appointments after the surgery. Participants in the trial can expect to provide feedback on their experiences, which will help researchers better understand the outcomes of this surgery. It’s important to know that the study is currently recruiting, so there are opportunities for eligible individuals to get involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations
- • Patient age ≥ 18 years
- • Transgender male, female of gender non-conforming patient with diagnosed gender dysphoria and the specific wish to undergo genital gender affirming surgery
- • Fit for operation, based on the surgeon's expert opinion
- • Patient is able and willing to attend the follow-up consultations
- Exclusion Criteria:
- • Absence of signed written informed consent and thus a patient unwilling to participate.
- • Patient age \< 18 years
- • Cisgender patients
- • Patients unfit for operation
- • Patient declares that it will be impossible for him to attend the follow-up consultations
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, East Flanders, Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials